Cetylated Fatty Acid Compositions with Reduced Antioxidants for Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing compositions of cetylated fatty acids for treating arthritis and inflammatory joint disorders are not stable over time, have adverse effects, and are not economically viable, while also lacking effective protection for the gastric mucosa and regulation of blood glucose levels.
Innovation Solution
Compositions comprising cetylated fatty acids with a reduced percentage of antioxidants, such as tert-butyl-hydroquinone, are formulated to enhance stability, reduce adverse effects, and provide economic advantages, while also protecting the gastric mucosa and regulating blood glucose levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If compositions comprise cetylated fatty acids with conventional antioxidant percentages (1-5%), then the compositions can provide basic stability protection, but they are not stable over time and have adverse effects
Solution Approach 1:
The patent changes the parameter of antioxidant concentration from conventional 1-5% to reduced percentages (0.01-0.5%), and simultaneously modifies the antioxidant composition to include specific compounds (tocopherols, ascorbyl palmitate, citric acid) in optimized ratios. This parameter optimization resolves the contradiction by achieving stability at lower antioxidant levels, reducing adverse effects while maintaining protective function.
Solution Approach 2:
The patent creates a composite antioxidant system combining multiple components (tocopherols, ascorbyl palmitate, citric acid) in specific proportions rather than using a single antioxidant agent. This composite approach enhances stability through synergistic effects while using lower total antioxidant percentages, thereby reducing adverse effects and improving reliability.
2Reliability
If compositions use higher percentages of antioxidants to improve stability, then stability increases, but production costs increase
Solution Approach 1:
The patent optimizes the parameter of antioxidant concentration by reducing it from conventional high levels to low percentages (0.01-0.5%), while compensating for stability through careful selection and combination of specific antioxidant compounds. This parameter change achieves cost reduction while maintaining stability, as lower antioxidant percentages reduce production costs but the optimized composition ensures sufficient protective effect.
Solution Approach 2:
The patent employs cost-effective antioxidant compounds that provide adequate stability protection at low concentrations. By selecting economically viable antioxidant agents and using them in optimized small amounts rather than large quantities, the composition achieves stability while minimizing production costs, making the product economically advantageous to produce.
3Ease of manufacture
If compositions are formulated without sufficient antioxidants, then production costs decrease, but they lack stability and effectiveness
Solution Approach 1:
The patent finds the optimal parameter balance by setting antioxidant percentages at low levels (0.01-0.5%) while carefully selecting and combining specific antioxidant compounds in optimized ratios. This parameter optimization ensures that sufficient stability is achieved at minimal antioxidant concentrations, resolving the contradiction between low cost and adequate stability protection.
Solution Approach 2:
The patent creates a composite antioxidant formulation combining multiple cost-effective compounds (tocopherols, ascorbyl palmitate, citric acid) in specific proportions. This composite approach provides adequate stability protection at low total antioxidant percentages, achieving both cost reduction and sufficient reliability through synergistic effects of multiple components working together at optimized concentrations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compositions effectively treat arthritis and inflammatory joint disorders, protect the gastric mucosa, and regulate blood glucose levels without adverse effects, maintaining stability and reducing production costs.
Implementation Method 1
the presence of the antioxidant makes the compositions of the invention stable over time, given that the titre of the active ingredient (cetylated fatty acids) remains almost unvaried over time, protecting the cetylated fatty acids from the action of the oxidising agents
Data Source
AI summary
A composition is described comprising a mixture of at least one cetylated fatty acid or a mixture of cetylated fatty acids and an antioxidant in reduced percentages by weight, and related methods for treatment of arthritis and of inflammatory joint and musculoskeletal pain. Furthermore composition is described comprising a mixture of at least one cetylated fatty acid or a mixture of cetylated fatty acids and, optionally, an antioxidant, and related treatment methods for protecting the gastric mucosa and for regulating the blood glucose levels. Additionally, a method is described for preparing the at least one cetylated fatty acid or mixture of cetylated fatty acids and for preparing compositions comprising the cetylated fatty acids and the antioxidant.